abmart-banner
Global R&D Pipeline
My Favorite
Hot Targets:
Home>AbMart>

Global R&D Pipeline

FPR2
Back
Total number of drugs
20
Phase II and later clinical stages
5%
Involving companies
17
Main therapeutic areas
Other Diseases
Data Table
Data Chart
Select Row
Fixed Column
Download Table
Molecule Info
R&D and Market Info
ADC Info
DrugDrug Name EnDrug TypeTreatment FieldMechanism of ActionOriginatorDeveloperIndicationHighest Development StageHighest Development Stage (China)Approved Countries/RegionsApproved TimeApproved Time (China)Special ReviewADC TypeADC LinkerADC PayloadADC DARDrug NameAntibody TypeADC Linking SiteOperation
Quin-C1Quin-C1Synthetic peptideOther DiseasesN-formyl peptide receptor 2 stimulantsUniversity of IllinoisUniversity of IllinoisPreclinicalQuin-C1
detail  >
FPR1/FPR2 Agonist(BMS)FPR1/FPR2 Agonist(BMS)Small molecule drugCardiovascular Diseases Respiratory Diseasesformyl peptide receptor 1 agonists N-formyl peptide receptor 2 stimulantsBristol Myers Squibb Co.DiscoveryFPR1/FPR2 Agonist(BMS)
detail  >
F2Pal16 pepducinsF2Pal16 pepducinsSynthetic peptideInfectious DiseasesN-formyl peptide receptor 2 modulatorsUniversity of GothenburgPreclinicalF2Pal16 pepducins
detail  >
F2Pal12 pepducinsF2Pal12 pepducinsSynthetic peptideInfectious DiseasesN-formyl peptide receptor 2 modulatorsUniversity of GothenburgPreclinicalF2Pal12 pepducins
detail  >
F2Pal10 pepducinsF2Pal10 pepducinsSynthetic peptideInfectious DiseasesN-formyl peptide receptor 2 modulatorsUniversity of GothenburgPreclinicalF2Pal10 pepducins
detail  >
ACT-389949ACT-389949Small molecule drugEndocrinology and Metabolic DiseaseN-formyl peptide receptor 2 stimulantsJohnson & JohnsonPendingACT-389949
detail  >
BMS-986235BMS-986235Small molecule drugOther DiseasesN-formyl peptide receptor 2 stimulantsBristol Myers Squibb Co.Phase 1BMS-986235
detail  >
AMS-21AMS-21Small molecule drugOther DiseasesN-formyl peptide receptor 2 stimulantsUniversità degli Studi di BresciaUniversità degli Studi di BresciaDiscoveryAMS-21
detail  >
WRW4WRW4Synthetic peptideEndocrinology and Metabolic DiseaseN-formyl peptide receptor 2 inhibitorsShandong UniversityShandong UniversityPreclinicalPreclinicalWRW4
detail  >
Tetrascorpin-1Tetrascorpin-1PeptidesImmune System Diseases Nervous System Diseases Other DiseasesN-formyl peptide receptor 2 stimulantsUniversity of Campania Luigi VanvitelliUniversity of Campania Luigi VanvitelliPreclinicalTetrascorpin-1
detail  >
Total 20 data
1
2